{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T04:50:46Z","timestamp":1787028646961,"version":"build-2736575974"},"reference-count":56,"publisher":"MDPI AG","issue":"12","license":[{"start":{"date-parts":[[2024,6,12]],"date-time":"2024-06-12T00:00:00Z","timestamp":1718150400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100006108","name":"NCATS of the NIH","doi-asserted-by":"publisher","award":["UL1TR002389"],"award-info":[{"award-number":["UL1TR002389"]}],"id":[{"id":"10.13039\/100006108","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JCM"],"abstract":"<jats:p>(1) Background\/Objectives: Dexmedetomidine is a sedative for patients receiving invasive mechanical ventilation (IMV) that previous single-site studies have found to be associated with improved survival in patients with COVID-19. The reported clinical benefits include dampened inflammatory response, reduced respiratory depression, reduced agitation and delirium, improved preservation of responsiveness and arousability, and improved hypoxic pulmonary vasoconstriction and ventilation-perfusion ratio. Whether improved mortality is evident in large, multi-site COVID-19 data is understudied. (2) Methods: The association between dexmedetomidine use and mortality in patients with COVID-19 receiving IMV was assessed. This retrospective multi-center cohort study utilized patient data in the United States from health systems participating in the National COVID Cohort Collaborative (N3C) from 1 January 2020 to 3 November 2022. The primary outcome was 28-day mortality rate from the initiation of IMV. Propensity score matching adjusted for differences between the group with and without dexmedetomidine use. Adjusted hazard ratios (aHRs) for 28-day mortality were calculated using multivariable Cox proportional hazards models with dexmedetomidine use as a time-varying covariate. (3) Results: Among the 16,357,749 patients screened, 3806 patients across 17 health systems met the study criteria. Mortality was lower with dexmedetomidine use (aHR, 0.81; 95% CI, 0.73\u20130.90; p &lt; 0.001). On subgroup analysis, mortality was lower with earlier dexmedetomidine use\u2014initiated within the median of 3.5 days from the start of IMV\u2014(aHR, 0.67; 95% CI, 0.60\u20130.76; p &lt; 0.001) as well as use prior to standard, widespread use of dexamethasone for patients on respiratory support (prior to 30 July 2020) (aHR, 0.54; 95% CI, 0.42\u20130.69; p &lt; 0.001). In a secondary model that was restricted to 576 patients across six health system sites with available PaO2\/FiO2 data, mortality was not lower with dexmedetomidine use (aHR 0.95, 95% CI, 0.72\u20131.25; p = 0.73); however, on subgroup analysis, mortality was lower with dexmedetomidine use initiated earlier than the median dexmedetomidine start time after IMV (aHR, 0.72; 95% CI, 0.53\u20130.98; p = 0.04) and use prior to 30 July 2020 (aHR, 0.22; 95% CI, 0.06\u20130.78; p = 0.02). (4) Conclusions: Dexmedetomidine use was associated with reduced mortality in patients with COVID-19 receiving IMV, particularly when initiated earlier, rather than later, during the course of IMV as well as use prior to the standard, widespread usage of dexamethasone during respiratory support. These particular findings might suggest that the associated mortality benefit with dexmedetomidine use is tied to immunomodulation. However, further research including a large randomized controlled trial is warranted to evaluate the potential mortality benefit of DEX use in COVID-19 and evaluate the physiologic changes influenced by DEX that may enhance survival.<\/jats:p>","DOI":"10.3390\/jcm13123429","type":"journal-article","created":{"date-parts":[[2024,6,12]],"date-time":"2024-06-12T06:47:30Z","timestamp":1718174850000},"page":"3429","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Association between Dexmedetomidine Use and Mortality in Patients with COVID-19 Receiving Invasive Mechanical Ventilation: A U.S. National COVID Cohort Collaborative (N3C) Study"],"prefix":"10.3390","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0716-9816","authenticated-orcid":false,"given":"John L.","family":"Hamilton","sequence":"first","affiliation":[{"name":"Rush Medical College, Rush University Medical Center, Chicago, IL 60612, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4797-8869","authenticated-orcid":false,"given":"Rachel","family":"Baccile","sequence":"additional","affiliation":[{"name":"Center for Health and the Social Sciences, University of Chicago, Chicago, IL 60637, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0654-6250","authenticated-orcid":false,"given":"Thomas J.","family":"Best","sequence":"additional","affiliation":[{"name":"Center for Health and the Social Sciences, University of Chicago, Chicago, IL 60637, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pankaja","family":"Desai","sequence":"additional","affiliation":[{"name":"Rush Medical College, Rush University Medical Center, Chicago, IL 60612, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alan","family":"Landay","sequence":"additional","affiliation":[{"name":"Rush Medical College, Rush University Medical Center, Chicago, IL 60612, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan C.","family":"Rojas","sequence":"additional","affiliation":[{"name":"Rush Medical College, Rush University Medical Center, Chicago, IL 60612, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6169-3873","authenticated-orcid":false,"given":"Markus A.","family":"Wimmer","sequence":"additional","affiliation":[{"name":"Rush Medical College, Rush University Medical Center, Chicago, IL 60612, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert A.","family":"Balk","sequence":"additional","affiliation":[{"name":"Rush Medical College, Rush University Medical Center, Chicago, IL 60612, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"on behalf of the N3C Consortium","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2024,6,12]]},"reference":[{"key":"ref_1","unstructured":"WHO (2020). COVID-19 Dashboard, World Health Organization. Available online: https:\/\/data.who.int\/dashboards\/covid19\/deaths?n=c."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1164\/rccm.202006-2405OC","article-title":"Case Fatality Rates for Patients with COVID-19 Requiring Invasive Mechanical Ventilation. A Meta-Analysis","volume":"203","author":"Lim","year":"2021","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"ref_3","doi-asserted-by":"crossref","unstructured":"Karagiannidis, C., Hentschker, C., Westhoff, M., Weber-Carstens, S., Janssens, U., Kluge, S., Pfeifer, M., Spies, C., Welte, T., and Rossaint, R. (2022). Observational study of changes in utilization and outcomes in mechanical ventilation in COVID-19. PLoS ONE, 17.","DOI":"10.1371\/journal.pone.0262315"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"e0876","DOI":"10.1097\/CCE.0000000000000876","article-title":"Intensive Care and Organ Support Related Mortality in Patients with COVID-19: A Systematic Review and Meta-Analysis","volume":"5","author":"Chandel","year":"2023","journal-title":"Crit. Care Explor."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.1001\/jamainternmed.2020.3596","article-title":"Factors Associated with Death in Critically Ill Patients with Coronavirus Disease 2019 in the US","volume":"180","author":"Gupta","year":"2020","journal-title":"JAMA Intern. Med."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1097\/ALN.0000000000001214","article-title":"From Bench to Bedside and Back Again: A Personal Journey with Dexmedetomidine","volume":"125","author":"Maze","year":"2016","journal-title":"Anesthesiology"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"776882","DOI":"10.3389\/fmed.2021.776882","article-title":"The Effect of Dexmedetomidine as a Sedative Agent for Mechanically Ventilated Patients with Sepsis: A Systematic Review and Meta-Analysis","volume":"8","author":"Wang","year":"2021","journal-title":"Front. Med."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1186\/s13054-019-2690-4","article-title":"The effect of dexmedetomidine and clonidine on the inflammatory response in critical illness: A systematic review of animal and human studies","volume":"23","author":"Flanders","year":"2019","journal-title":"Crit. Care"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1111\/bph.15363","article-title":"Emerging benefits and drawbacks of alpha(2)-adrenoceptor agonists in the management of sepsis and critical illness","volume":"178","author":"Lankadeva","year":"2021","journal-title":"Br. J. Pharmacol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1097\/CCM.0000000000003262","article-title":"Corticosteroids in Sepsis: An Updated Systematic Review and Meta-Analysis","volume":"46","author":"Rochwerg","year":"2018","journal-title":"Crit. Care Med."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"28336","DOI":"10.1073\/pnas.2018030117","article-title":"Transcriptional and proteomic insights into the host response in fatal COVID-19 cases","volume":"117","author":"Wu","year":"2020","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1056\/NEJMoa2021436","article-title":"Dexamethasone in Hospitalized Patients with COVID-19","volume":"384","author":"Group","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"ref_13","doi-asserted-by":"crossref","unstructured":"WHO Rapid Evidence Appraisal for COVID-19 Therapies (REACT) Working Group, Sterne, J.A.C., Murthy, S., Diaz, J.V., Slutsky, A.S., Villar, J., Angus, D.C., Annane, D., Azevedo, L.C.P., and Berwanger, O. (2020). Association between Administration of Systemic Corticosteroids and Mortality among Critically Ill Patients with COVID-19: A Meta-Analysis. JAMA, 324, 1330\u20131341.","DOI":"10.1001\/jama.2020.17023"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"e33","DOI":"10.1016\/j.bja.2020.09.031","article-title":"Potential therapeutic value of dexmedetomidine in COVID-19 patients admitted to ICU","volume":"126","author":"Zhao","year":"2021","journal-title":"Br. J. Anaesth."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"e35","DOI":"10.1016\/j.bja.2020.10.010","article-title":"Dexmedetomidine: Another arrow in the quiver to fight COVID-19 in intensive care units","volume":"126","author":"Jain","year":"2021","journal-title":"Br. J. Anaesth."},{"key":"ref_16","first-page":"S86","article-title":"Potential Sedative and Therapeutic Value of Dexmedetomidine in Critical COVID-19 Patients","volume":"27","author":"Safari","year":"2021","journal-title":"Pharm. Sci."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"3023","DOI":"10.4049\/jimmunol.1400255","article-title":"Prevention of neutrophil extravasation by alpha2-adrenoceptor-mediated endothelial stabilization","volume":"193","author":"Machado","year":"2014","journal-title":"J. Immunol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1097\/ALN.0000000000000491","article-title":"Dexmedetomidine attenuates the microcirculatory derangements evoked by experimental sepsis","volume":"122","author":"Miranda","year":"2015","journal-title":"Anesthesiology"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1097\/ALN.0000000000001135","article-title":"Effects of Dexmedetomidine on Intestinal Microcirculation and Intestinal Epithelial Barrier in Endotoxemic Rats","volume":"125","author":"Yeh","year":"2016","journal-title":"Anesthesiology"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"107709","DOI":"10.1016\/j.intimp.2021.107709","article-title":"The immunomodulatory mechanism of dexmedetomidine","volume":"97","author":"Yuki","year":"2021","journal-title":"Int. Immunopharmacol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1097\/00000542-199212000-00013","article-title":"Effects of intravenous dexmedetomidine in humans. I. Sedation, ventilation, and metabolic rate","volume":"77","author":"Belleville","year":"1992","journal-title":"Anesthesiology"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1186\/cc712","article-title":"Respiratory effects of dexmedetomidine in the surgical patient requiring intensive care","volume":"4","author":"Venn","year":"2000","journal-title":"Crit. Care"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1111\/anae.14472","article-title":"The effect of dexmedetomidine on delirium and agitation in patients in intensive care: Systematic review and meta-analysis with trial sequential analysis","volume":"74","author":"Ng","year":"2019","journal-title":"Anaesthesia"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1001\/jama.2012.304","article-title":"Dexmedetomidine vs midazolam or propofol for sedation during prolonged mechanical ventilation: Two randomized controlled trials","volume":"307","author":"Jakob","year":"2012","journal-title":"JAMA"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"2247.e1","DOI":"10.1016\/j.ajem.2020.05.066","article-title":"Dexmedetomidine and worsening hypoxemia in the setting of COVID-19: A case report","volume":"38","author":"Stockton","year":"2020","journal-title":"Am. J. Emerg. Med."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1111\/aas.13970","article-title":"Hemodynamic and respiratory effects of dexmedetomidine sedation in critically ill COVID-19 patients: A retrospective cohort study","volume":"65","author":"Uusalo","year":"2021","journal-title":"Acta Anaesthesiol. Scand."},{"key":"ref_27","first-page":"2457","article-title":"Effects of Dexmedetomidine and Propofol on Hemodynamic Stability and Ventilation Time in Patients Suffering COVID-19 Admitting to Intensive Care Units","volume":"25","author":"Ghajarzadeh","year":"2021","journal-title":"Ann. Rom. Soc. Cell Biol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"797647","DOI":"10.3389\/fmed.2021.797647","article-title":"The Association of an Alpha-2 Adrenergic Receptor Agonist and Mortality in Patients with COVID-19","volume":"8","author":"Hamilton","year":"2021","journal-title":"Front. Med."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"5","DOI":"10.17816\/clinpract88180","article-title":"The effectiveness of dexmedetomidine in patients with severe COVID-19","volume":"12","author":"Andreychenko","year":"2021","journal-title":"J. Clin. Pract."},{"key":"ref_30","unstructured":"(2022, December 09). About the National COVID Cohort Collaborative, Available online: https:\/\/ncats.nih.gov\/n3c\/about."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1093\/jamia\/ocaa196","article-title":"The National COVID Cohort Collaborative (N3C): Rationale, design, infrastructure, and deployment","volume":"28","author":"Haendel","year":"2021","journal-title":"J. Am. Med. Inform. Assoc."},{"key":"ref_32","unstructured":"(2024, April 01). Latest Phenotype \u00b7 National-COVID-Cohort-Collaborative\/Phenotype_Data_Acquisition Wiki (github.com). Available online: https:\/\/github.com\/National-COVID-Cohort-Collaborative\/Phenotype_Data_Acquisition\/wiki\/Latest-Phenotype."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1016\/S0140-6736(07)61602-X","article-title":"The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: Guidelines for reporting observational studies","volume":"370","author":"Altman","year":"2007","journal-title":"Lancet"},{"key":"ref_34","unstructured":"(2022, December 09). N3C Privacy-Preserving Record Linkage. Available online: https:\/\/covid.cd2h.org\/PPRL."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"e223890","DOI":"10.1001\/jamanetworkopen.2022.3890","article-title":"Association of Early Aspirin Use with In-Hospital Mortality in Patients with Moderate COVID-19","volume":"5","author":"Chow","year":"2022","journal-title":"JAMA Netw. Open"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1093\/aje\/kwq433","article-title":"Updating and validating the Charlson comorbidity index and score for risk adjustment in hospital discharge abstracts using data from 6 countries","volume":"173","author":"Quan","year":"2011","journal-title":"Am. J. Epidemiol."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1186\/s13054-019-2663-7","article-title":"The SOFA score-development, utility and challenges of accurate assessment in clinical trials","volume":"23","author":"Lambden","year":"2019","journal-title":"Crit. Care"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1164\/rccm.201706-1172OC","article-title":"Corticosteroid Therapy for Critically Ill Patients with Middle East Respiratory Syndrome","volume":"197","author":"Arabi","year":"2018","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"ref_39","unstructured":"Team, R.C. (2022, December 20). R: A Language and Environment for Statistical Computing. R Foundation for Statistical Computing. Available online: https:\/\/www.R-project.org\/."},{"key":"ref_40","unstructured":"Therneau, T.M. (2022, December 20). A Package for Survival Analysis in R. Available online: https:\/\/CRAN.R-project.org\/package=survival."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1214\/09-STS313","article-title":"Matching methods for causal inference: A review and a look forward","volume":"25","author":"Stuart","year":"2010","journal-title":"Stat. Sci."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"eabi6110","DOI":"10.1126\/sciadv.abi6110","article-title":"Cannabidiol inhibits SARS-CoV-2 replication through induction of the host ER stress and innate immune responses","volume":"8","author":"Nguyen","year":"2022","journal-title":"Sci. Adv."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1038\/s41577-020-0311-8","article-title":"The trinity of COVID-19: Immunity, inflammation and intervention","volume":"20","author":"Tay","year":"2020","journal-title":"Nat. Rev. Immunol."},{"key":"ref_44","first-page":"L1","article-title":"Effects of endogenous and exogenous catecholamines on LPS-induced neutrophil trafficking and activation","volume":"276","author":"Abraham","year":"1999","journal-title":"Am. J. Physiol."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1016\/S0140-6736(20)30691-7","article-title":"Immunosuppression for hyperinflammation in COVID-19: A double-edged sword?","volume":"395","author":"Ritchie","year":"2020","journal-title":"Lancet"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1159\/000512063","article-title":"Early Use of Corticosteroid May Prolong SARS-CoV-2 Shedding in Non-Intensive Care Unit Patients with COVID-19 Pneumonia: A Multicenter, Single-Blind, Randomized Control Trial","volume":"100","author":"Tang","year":"2021","journal-title":"Respiration"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"1202504","DOI":"10.3389\/fmed.2023.1202504","article-title":"Corticosteroids in COVID-19: Pros and cons","volume":"10","author":"Bahsoun","year":"2023","journal-title":"Front. Med."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"e01219","DOI":"10.1016\/j.idcr.2021.e01219","article-title":"Central catecholaminergic blockade with clonidine prevent SARS-CoV-2 complication: A case series","volume":"25","author":"Hyoju","year":"2021","journal-title":"IDCases"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1097\/CCM.0000000000004938","article-title":"Prone Positioning and Survival in Mechanically Ventilated Patients with Coronavirus Disease 2019-Related Respiratory Failure","volume":"49","author":"Mathews","year":"2021","journal-title":"Crit. Care Med."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1177\/08850666231224395","article-title":"Impact of Sedation Practices on Mortality in COVID-19-Associated Adult Respiratory Distress Syndrome Patients: A Multicenter Retrospective Descriptive Study","volume":"39","author":"Alwakeel","year":"2024","journal-title":"J. Intensive Care Med."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1016\/j.cmi.2021.03.003","article-title":"Methodological evaluation of bias in observational coronavirus disease 2019 studies on drug effectiveness","volume":"27","author":"Martinuka","year":"2021","journal-title":"Clin. Microbiol. Infect."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.jcrc.2016.07.017","article-title":"Immortal time bias in observational studies of time-to-event outcomes","volume":"36","author":"Jones","year":"2016","journal-title":"J. Crit. Care"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1093\/aje\/kwm324","article-title":"Immortal time bias in pharmaco-epidemiology","volume":"167","author":"Suissa","year":"2008","journal-title":"Am. J. Epidemiol."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1016\/j.bja.2019.07.027","article-title":"Effects of dexmedetomidine on perioperative stress, inflammation, and immune function: Systematic review and meta-analysis","volume":"123","author":"Wang","year":"2019","journal-title":"Br. J. Anaesth."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1007\/s40262-017-0507-7","article-title":"Clinical Pharmacokinetics and Pharmacodynamics of Dexmedetomidine","volume":"56","author":"Weerink","year":"2017","journal-title":"Clin. Pharmacokinet."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1007\/s40265-015-0419-5","article-title":"Dexmedetomidine: A Review of Its Use for Sedation in the Intensive Care Setting","volume":"75","author":"Keating","year":"2015","journal-title":"Drugs"}],"container-title":["Journal of Clinical Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2077-0383\/13\/12\/3429\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T14:57:18Z","timestamp":1760108238000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2077-0383\/13\/12\/3429"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6,12]]},"references-count":56,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2024,6]]}},"alternative-id":["jcm13123429"],"URL":"https:\/\/doi.org\/10.3390\/jcm13123429","relation":{},"ISSN":["2077-0383"],"issn-type":[{"value":"2077-0383","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,6,12]]}}}